DUBLIN--(BUSINESS WIRE)--The "Global Extra Corporeal Membrane Oxygenation (ECMO) System Market - Segmented by Method, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global extra corporeal membrane oxygenation system market is expected to register a CAGR of 3.6%, during the forecast period.
North America dominates the global market, due to the favorable reimbursement scenario and increasing incidences of lung cancer in the region. Moreover, the presence of large number of ECMO centers in the United States are also contributing to the growth of market.
Cardiovascular diseases are the leading cause of death globally. According to the WHO in 2017, 17.7 million people died from cardiovascular diseases, accounting for 31% of all global deaths, and 7.4 million people died from coronary heart disease. Factors, such as, increasing use of tobacco and alcohol, unhealthy diet, and physical inactivity are leading to the rise in cardiovascular diseases, further driving the market.
In addition, technological advancement, rising instances of the chronic obtrusive pulmonary disease (COPD), and increased adoption of ECMO machines are fuelling the growth of global ECMO system market.
As per the American Heart Association, coronary heart disease is the leading cause of deaths (45.1%), followed by cardiovascular disease in the United States, stroke (16.5%), and heart failure (8.5%). About 5.7 million adults in the United States die of a heart failure every year and ECMO has the potential to reduce the percentage of in-hospital failures. Thus, increasing adoption is fuelling the growth of global ECMO market in that region.
- July, 2017: Castor Branched Aortic Stent-Graft System receives approval from China Food and Drug Administration (CFDA) on 11 July 2017.
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
7. Market Segmentation
8. Competitive Landscape
9. Key Players
- Alung Technologies Inc.
- Getinge Group
- Livanova PLC
- Microport Scientific Corporation
- Nipro Medical Corporation
- Terumo Meical Corporation
- Xenios AG
10. Future Outlook of the Market
For more information about this report visit https://www.researchandmarkets.com/research/lm6dvd/global_extra?w=4